Document is current
Any future updates will be listed below
-
Authors
Tok, S.
Maurin, H.
Delay, C.
Crauwels, D.
Manyakov, N. V.
Van Der Elst, W.
Moechars, D.
Drinkenburg, W. H. I. M. http://orcid.org/0000-0002-1095-7995
-
Funding
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (765549, project ‘M-GATE’)
- License Information
-
More Information
Article History
Received: 27 April 2022
Accepted: 7 June 2022
First Online: 23 June 2022
Declarations
:
: All in vivo and in vitro studies were performed in strict accordance with the guidelines of the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) and with the European Council Directive of 24 November 1986 (86/609/EEC) and European Ethics Committee directive (2010/63/EU) for the protection of laboratory animals. In line with Belgian governmental directives all protocols were approved by the Animal Care and Use Committee of Janssen Pharmaceutica NV.
: Not applicable.
: The authors declare that they are working for Janssen Pharmaceutica NV. The authors declare no other commercial or financial relationships that could be construed as a potential conflict of interest.
